REFERENCES

1. Thanvi BR, Lo TC. Update on myasthenia gravis. Postgrad Med J 2004;80:690-700.

2. Phillips LH. The epidemiology of myasthenia gravis. Semin Neurol 2004;24:17-20.

3. Peng DT, Xu XH, Yu ZY. Determination study of neostigmine test results. Chin J Neuroimmunol Neurol 2007;14:1-3.

4. Zivkovic SA, Shipe C. Use of repetitive nerve stimulation in the evaluation of neuromuscular junction disorders. Am J Electroneurodiagnostic Technol 2005;45:248-261.

5. Cui LY, Guan YZ, Wang H, Tang XF. Single fiber electromyography in th e diagnosis of ocular myasthenia gravis: report of 90 cases. Chin Med J (Engl) 2004;117:848-51.

6. Cont-i Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J Clin Invest 2006;16:2843-54.

7. Shigemoto K. Myasthenia gravis induced by autoantibodies against MuSK. Acta Myol 2007;26:185-91.

8. Meriggioli MN, Sanders DB. Advances in the diagnosis of neuromuscular junction disorders. Am J Phys Med Rehabil 2005;84:627-38.

9. Benatar M. A systematic review of diagnostic studies in myasthenia gravis. Neuromuscul Disord 2006;16:459-67.

10. Keesey JC. Clinical evaluation and management of myasthenia gravis. Muscle Nerve 2004;29:484-505.

11. Skeie GO, Apostolski S, Evoli A, Gilhus NE, Illa I, Harms L, Hilton-Jones D, Melms A, Verschuuren J, Horge HW, European Federation of Neurological Societies. Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 2010;17:893-902.

12. Jani-Acsadi A, Lisak RP. Myasthenia gravis. Curr Treat Options Neurol 2010;12:231-43.

13. Luchanok U, Kaminski HJ. Ocular myasthenia: diagnostic and treatment recommendations and the evidence base. Curr Opin Neurol 2008;21:8-15.

14. Zhang W, Li ZY. Progress of ocular myasthenia gravis. Chin J Neurol 2007;40:564-6.

15. Antonio-Santos AA, Eggen berger ER. Medical treatment options for ocular myasthenia gravis. Curr Opin Ophthalmol 2008;19:468-78.

16. Jani-Acsadi A, Lisak RP. Myasthenic crisis: guidelines for prevention and treatment. J Neurol Sci 2007;261:127-33.

17. Chaudhuri A, Behan PO. Myasthenic crisis. QJM 2009;102:97-107.

18. Bershad EM, Feen ES, Suarez JI. Myasthenia gravis crisis. South Med J 2008;101:63-69.

19. Parr JR, Jayawant S. C hildhood myasthenia: clinical subtypes and practical management. Dev Med Child Neurol 2007;49:629-35.

20. Evoli A. Acquired myasthenia gravis in childhood. Curr Opin Neurol 2010;23:536-40.

21. Chiang LM, Darras BT, Kang PB. Juvenile myasthenia gravis. Muscle Nerve 2009;39:423-31.

22. Juel VC, Massey JM. Myasthenia gravis. Orphanet J Rare Dis 2007;2:44.

Neuroimmunology and Neuroinflammation
ISSN 2349-6142 (Online) 2347-8659 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/